# An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects

> **NCT01195532** · — · UNKNOWN · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Hyperglycemia
- Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01195532
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195532, "An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01195532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*